Yipinhong Pharmaceutical Co Ltd Class A Financial Flexibility Index
Yipinhong Pharmaceutical Co Ltd Class A financial flexibility index. Yipinhong Pharmaceutical Co Ltd Class A (300723) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥28.33 Million (operating CF CN¥14.81 Million minus capex CN¥13.52 Million) represents 0% of total liabilities (CN¥2.73 Billion). Explore capital reinvestment ratio of Yipinhong Pharmaceutical Co Ltd Class A to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
Financial flexibility index of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. Historical Financial Flexibility Index trend for Yipinhong Pharmaceutical Co Ltd Class A across 13 annual periods. Check total reinvestment intensity of Yipinhong Pharmaceutical Co Ltd Class A to assess the company's total reinvestment commitment from operating cash flow.
Yipinhong Pharmaceutical Co Ltd Class A Financial Flexibility Index by Year (2013–2025)
Yipinhong Pharmaceutical Co Ltd Class A financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Yipinhong Pharmaceutical Co Ltd Class A. For the full cash flow conversion analysis, see cash flow conversion of Yipinhong Pharmaceutical Co Ltd Class A.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | CN¥173.22 Million | CN¥46.01 Million | CN¥2.64 Billion | ▲ +170.3% |
| 2024 | -0.09x | CN¥-230.67 Million | CN¥-550.42 Million | CN¥2.47 Billion | ▼ -121.3% |
| 2023 | 0.44x | CN¥792.51 Million | CN¥458.05 Million | CN¥1.81 Billion | ▼ -21.6% |
| 2022 | 0.56x | CN¥1.08 Billion | CN¥475.53 Million | CN¥1.93 Billion | ▼ -5.6% |
| 2021 | 0.59x | CN¥999.33 Million | CN¥438.10 Million | CN¥1.69 Billion | ▼ -34.6% |
| 2020 | 0.91x | CN¥589.37 Million | CN¥275.22 Million | CN¥650.14 Million | ▲ +6.7% |
| 2019 | 0.85x | CN¥385.87 Million | CN¥280.65 Million | CN¥454.20 Million | ▼ -17.4% |
| 2018 | 1.03x | CN¥495.37 Million | CN¥238.60 Million | CN¥481.67 Million | ▲ +126.1% |
| 2017 | 0.45x | CN¥169.84 Million | CN¥141.35 Million | CN¥373.45 Million | ▲ +8.3% |
| 2016 | 0.42x | CN¥174.56 Million | CN¥146.01 Million | CN¥415.82 Million | ▲ +134.8% |
| 2015 | 0.18x | CN¥76.88 Million | CN¥34.55 Million | CN¥429.90 Million | ▼ -10.4% |
| 2014 | 0.20x | CN¥120.95 Million | CN¥8.74 Million | CN¥606.28 Million | ▼ -79.8% |
| 2013 | 0.99x | CN¥223.26 Million | CN¥135.68 Million | CN¥225.66 Million | — |